Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PREPOPIK

CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE

Standard Dose
12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PREPOPIK is listed in Drugs@FDA under application 202535 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE Form and strength FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FERRING PHARMS INC Submission history Latest submission status date: 2023-08-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview PREPOPIK is listed in Drugs@FDA under application 202535 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE Form and strength FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FERRING PHARMS INC Submission history Latest submission status date: 2023-08-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.